Ray Therapeutics Gets $8M Grant to Work on New Gene Therapy for Vision Loss Disease In a significant milestone for the field of regenerative medicine and vision restoration, Ray Therapeutics—a clinical-stage biotechnology company specializing in optogenetic gene therapies—has been awarded…
Gilead Sciences Reports Financial Results for First Quarter 2025 Gilead Sciences, Inc. (Nasdaq: GILD) has unveiled its financial and operational performance for the first quarter of 2025, underscoring a steady start to the year that reflects both commercial momentum and…
GSK Invests $4 Million in Adult Vaccination Efforts, Doubling Down with New 2025 Commitment In a major push to improve adult immunization rates across the United States, GSK plc has announced the 15 recipients of its 2024 COiMMUNITY Initiative grant…
Kashiv BioSciences Obtains $150 Million in Debt Financing from GoldenTree Asset Management Kashiv BioSciences, LLC (“Kashiv” or “the Company”), a fully integrated and innovation-driven biopharmaceutical company, announced today the successful execution of a senior secured credit agreement with GoldenTree Asset…
$23.3Bn Antibody-Drug Conjugate Market Trends & Forecasts, 2035: 530+ Therapies, 140+ Developers The antibody-drug conjugate (ADC) market is poised for significant growth, with projections indicating an increase from USD 7.72 billion in the current year to USD 23.3 billion by…
MANSCAPED Unveils TCS Ball Hero Bundle for Testicular Cancer Awareness MANSCAPED, the global leader in men’s grooming, has built a reputation not only for its innovative grooming products and clever marketing but also for its commitment to a cause that…
Ono & Reborna Partner for CNS RNA-Targeting Drug Discovery Ono Pharmaceutical Co., Ltd. (Headquartered in Osaka, Japan; President and COO: Toichi Takino; hereafter referred to as “Ono”) has announced a strategic collaboration agreement with Reborna Biosciences, Inc. (Headquartered in Kanagawa,…
Novotech Secures Investment from GIC, Temasek, and TPG to Drive Global Expansion Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), has announced a significant investment from leading global investors GIC and Temasek. The two firms have signed…
Nosis Biosciences and Daiichi Sankyo Partner to Advance RNA Medicines Nosis Biosciences, an AI-driven biotechnology company specializing in RNA therapeutics for challenging cell types, has announced a Research Collaboration and Option Agreement with Daiichi Sankyo. This collaboration aims to leverage…
Agenus Reports Q4 2024 Results, Strengthens BOT/BAL Program Agenus Reports Q4 and Full-Year 2024 Financial and Operational Results, Implements Strategic Cost Reductions to Enhance Sustainability of BOT/BAL Program Agenus Inc. (“Agenus” or the “Company”) (Nasdaq: AGEN), a leading immuno-oncology company…
RoslinCT and Ayrmid Pharma Ltd. Plan Strategic Partnership for Omisirge® Manufacturing Ayrmid Pharma Ltd., a pioneering company in cell therapy focused on transforming cells into powerful therapeutics, and RoslinCT, a world-leading contract development and manufacturing organization (CDMO) specializing in cell…
bioAffinity Cuts $4M in Costs to Boost CyPath® Lung Sales bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company dedicated to advancing noninvasive diagnostic solutions for early-stage lung cancer and other respiratory diseases, has announced a series of strategic actions…